|
Volumn 21, Issue 1, 2001, Pages 85-88
|
The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GINKGO BILOBA EXTRACT;
HALOPERIDOL;
SUPEROXIDE DISMUTASE;
ADULT;
ANTIOXIDANT ACTIVITY;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG POTENTIATION;
ENZYME BLOOD LEVEL;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
CHRONIC DISEASE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
GINKGO BILOBA;
HALOPERIDOL;
HUMANS;
MALE;
MIDDLE AGED;
PHYTOTHERAPY;
PLANT EXTRACTS;
PLANTS, MEDICINAL;
SCHIZOPHRENIA;
SUPEROXIDE DISMUTASE;
TREATMENT OUTCOME;
|
EID: 0035142360
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200102000-00015 Document Type: Article |
Times cited : (73)
|
References (19)
|